Evidence map›Paper›PMID 37111327›Full record

ReviewPharmaceuticals (Basel, Switzerland)2023

Baicalin-Current Trends in Detection Methods and Health-Promoting Properties.

Agata Bajek-Bil, Marcelina Chmiel, Aleksandra Włoch, Monika Stompor-Gorący

Abstract readReview
In one paragraph

Review in Pharmaceuticals (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Baicalin nano-micelles for dry eye disease: LC-MS/MS method validation, pharmacokinetics and pharmacodynamics in preclinical models.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2025
    Article
  9. Review
  10. Baicalin plays a protective role by regulating ferroptosis in multiple diseases.Naunyn-Schmiedeberg's archives of pharmacology · 2025
    Review
  11. Review
  12. Flavonoids as Chemosensitizers in Leukemias.Advances in experimental medicine and biology · 2025
    Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Agata Bajek-BilFaculty of Chemistry, Rzeszow University of Technology, 35-959 Rzeszów, Poland.
Marcelina ChmielInstitute of Medical Sciences, University of Rzeszów, 35-959 Rzeszów, Poland.
Aleksandra WłochDepartment of Physics and Biophysics, Wrocław University of Environmental and Life Sciences, 50-375 Wrocław, Poland.ORCID 0000-0001-7610-5456
Monika Stompor-GorącyInstitute of Medical Sciences, University of Rzeszów, 35-959 Rzeszów, Poland.ORCID 0000-0001-5618-8899

Funding

National Science Center 2020/39/D/NZ9/02023
6 · The paper itself

Abstract

Baicalin (7-D-glucuronic acid-5,6-dihydroxyflavone) belongs to natural flavonoids extracted from the roots of

Indexed as

baicalinbiosensorsdetection methodsliquid chromatographypharmacological effectsScutellaria baicalensis

Identifiers

PMID37111327
PMCPMC10146343

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.